Elanco Animal Health Incorporated (ELAN) Financial Statements
Elanco Animal Health Incorporated (ELAN) reported trailing twelve-month revenue of $5.0B (up 12.0% year on year) and net income of -$199.0M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $379.0M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ELANElanco Animal Health IncorporatedFollow ELAN — free
—
Price chart with a free account
- Market cap
- 11.3B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 6 Nov, in 13 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.07 | 3.07 | 3.27 | 4.76 | 4.41 | 4.42 | 4.44 | 4.72 | 5.02 | |
| Gross profit | 1.49 | 1.60 | 1.61 | 2.63 | 2.50 | 2.49 | 2.44 | 2.59 | 2.78 | |
| Research & development | 0.25 | 0.27 | 0.33 | 0.37 | 0.32 | 0.33 | 0.34 | 0.37 | 0.37 | |
| Pre-tax income | 0.11 | 0.08 | -0.68 | -0.57 | -0.07 | -1.20 | 0.49 | -0.22 | -0.17 | |
| Income tax | 0.03 | 0.01 | -0.10 | -0.09 | 0.01 | 0.04 | 0.15 | 0.01 | 0.03 | |
| Net income | 0.09 | 0.07 | -0.57 | -0.48 | -0.08 | -1.23 | 0.34 | -0.23 | -0.20 | |
| Diluted EPS ($) | 0.28 | 0.18 | -1.30 | -0.99 | -0.16 | -2.50 | 0.68 | -0.47 | -0.41 | |
| Diluted shares (bn) | — | 0.370 | 0.441 | 0.487 | 0.488 | 0.492 | 0.497 | 0.496 | — |
USD billions · SEC XBRL
Elanco Animal Health Incorporated — questions
- What is Elanco Animal Health Incorporated's revenue?
- $5.0B over the twelve months to 2026-06-30, up 12.0% year on year, from its 10-Q and 10-K filings.
- What is Elanco Animal Health Incorporated's net income?
- -$199.0M over the twelve months to 2026-06-30.
- What is Elanco Animal Health Incorporated's free cash flow?
- $379.0M over the twelve months to 2026-06-30.
- What are Elanco Animal Health Incorporated's diluted earnings per share?
- $-0.41 over the twelve months to 2026-06-30.
Every figure on this page comes from Elanco Animal Health Incorporated's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.